Literature DB >> 8660166

Effectiveness of entoptic perimetry for locating peripheral scotomas caused by cytomegalovirus retinitis.

D J Plummer1, J F Arevalo, N Fram, J I Quiceno, P A Sample, W R Freeman.   

Abstract

OBJECTIVE: To determine the the effectiveness of random particle motion, presented on a computer monitor, as a noninvasive test for detecting cytomegalovirus retinitis.
DESIGN: A prospective masked study in which patients were asked to trace out any disturbances on a transparency placed over a computer monitor that displayed continuous random particle motion, while the patient fixated on a central spot (entoptic perimetry).
SETTING: The Acquired Immunodeficiency Syndrome Ocular Research Unit at the University of California, San Diego, in La Jolla. PATIENTS: Twenty-two men with cytomegalovirus retinitis who were positive for human immunodeficiency virus, 11 men without cytomegalovirus retinitis who were positive for human immunodeficiency virus, and eight men who were negative for human immunodeficiency virus. INTERVENTION: None. MEASUREMENTS: Sensitivities and specificities were used to compare the results of entoptic perimetry with fundus photographs.
RESULTS: Entoptic perimetry demonstrated a 95% sensitivity and a 95% specificity in detection of cytomegalovirus retinitis.
CONCLUSION: Entoptic perimetry may be an effective and inexpensive screening test for cytomegalovirus retinitis in hospitals and community clinics.

Entities:  

Mesh:

Year:  1996        PMID: 8660166     DOI: 10.1001/archopht.1996.01100140042005

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  2 in total

1.  Scanning laser entoptic perimetry for the detection of visual defects associated with diabetic retinopathy.

Authors:  M El-Bradey; D J Plummer; D Uwe-Bartsch; W R Freeman
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

2.  Screening for CMV retinitis using chromatic discrimination thresholds and achromatic contrast sensitivity.

Authors:  R S Newsom; G L Ong; T L Jackson; I Coldrick; L G Ripley; M Fisher; A G Casswell
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.